Yarrow Bioscience YARW
NASDAQ YARW
$23.84 +0.24 (+1.02%)
As of: Oct 2, 2026 · 9:38 AM EDT

Yarrow Bioscience (YARW) Liabilities and Shareholders Equity (2016 - 2026)

Updated

Yarrow Bioscience's Liabilities and Shareholders Equity was $23.6 million in Q2 2026, down 47.2% from $44.72 million a year earlier and down 8.8% from the prior quarter.

Analysis

Yarrow Bioscience (YARW) Liabilities and Shareholders Equity (2016 - 2026) Analysis & Trends

At the end of FY2025, Liabilities and Shareholders Equity at Yarrow Bioscience came in at $30.16 million, down 54.9% from FY2024.

  • Liabilities and Shareholders Equity shows a five-year compound annual growth rate of -20.3% (FY2020 to FY2025).
  • In earlier years, Liabilities and Shareholders Equity was $66.91 million in FY2024 (-31.5%), $97.69 million in FY2023 (+139.7%), $40.76 million in FY2022 (-39.2%) and $67.05 million in FY2021 (-28.5%).
  • The Q2 2026 figure marks the lowest quarterly Liabilities and Shareholders Equity since Q3 2023.
  • Compared with a year earlier, Liabilities and Shareholders Equity has declined for three straight quarters, with growth averaging 3.0% over the last seven quarters.
  • The best year-over-year quarter for Liabilities and Shareholders Equity over five years was Q3 2024 (growth of 295.5%); the worst was Q3 2023 (a decline of 58.9%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Yarrow Bioscience 19.32 Mn -97.19 Mn - 23.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 23.60 Mn
Mar 31, 2026 25.87 Mn
Dec 31, 2025 30.16 Mn
Jun 30, 2025 44.72 Mn
Mar 31, 2025 56.42 Mn
Dec 31, 2024 66.91 Mn
Sep 30, 2024 76.20 Mn
Jun 30, 2024 86.65 Mn
Mar 31, 2024 91.68 Mn
Dec 31, 2023 97.69 Mn
Sep 30, 2023 19.27 Mn
Jun 30, 2023 24.96 Mn
Mar 31, 2023 35.26 Mn
Dec 31, 2022 40.76 Mn
Sep 30, 2022 46.91 Mn
Jun 30, 2022 55.19 Mn
Mar 31, 2022 64.32 Mn
Dec 31, 2021 67.05 Mn
Sep 30, 2021 81.32 Mn
Jun 30, 2021 133.98 Mn
API Access

Yarrow Bioscience Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=YARW&period=max&api_key=YOUR_API_KEY